Effect of prolonged standardized bed rest on cystatin C and other markers of cardiovascular risk

BMC Physiology

Volumn 11, Issue 1, 2011, Pages

  Arinell, Karin ^a   Christensen, Kjeld ^a   Blanc, Stéphane ^b   Larsson, Anders ^c   Fröbert, Ole ^a  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BIOLOGICAL MARKER; CYSTATIN C;

ADULT; ARTICLE; BED REST; BLOOD; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SUPINE POSITION; TIME;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BED REST; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CYSTATIN C; EXERCISE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; RISK FACTORS; SUPINE POSITION; TIME FACTORS;

EID: 83055192077     PISSN: None     EISSN: 14726793     Source Type: Journal    
DOI: 10.1186/1472-6793-11-17     Document Type: Article

References (29)

1. Markers of inflammation are inversely related to physical activity and fitness in sedentary men with treated hypertension. Hjelstuen A, Anderssen SA, Holme I, Seljeflot I, Klemsdal TO, Am J Hypertens 2006 19 669 675 discussion 676-667 10.1016/j.amjhyper.2005.11.012 16814119 (Pubitemid 43928517)
2. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. Mora S, Lee IM, Buring JE, Ridker PM, JAMA 2006 295 1412 1419 10.1001/jama.295.12.1412 16551713
3. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events. Mora S, Rifai N, Buring JE, Ridker PM, Circulation 2006 114 381 387 10.1161/CIRCULATIONAHA.106.634089 16864722 (Pubitemid 44264819)
4. Cystatin C for estimation of glomerular filtration rate in patients with spinal cord injury. Jenkins MA, Brown DJ, Ierino FL, Ratnaike SI, Ann Clin Biochem 2003 40 364 368 10.1258/000456303766476995 12880536 (Pubitemid 36819553)
5. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE, Kidney Int 2004 65 1416 1421 10.1111/j.1523-1755.2004.00517.x 15086483 (Pubitemid 38406982)
6. Modulation of phagocytosis-associated respiratory burst by human cystatin C: role of the N-terminal tetrapeptide Lys-Pro-Pro-Arg. Leung-Tack J, Tavera C, Gensac MC, Martinez J, Colle A, Exp Cell Res 1990 188 16 22 10.1016/0014-4827(90)90272-C 2158459 (Pubitemid 20147848)
7. Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study). Parikh NI, Hwang SJ, Yang Q, Larson MG, Guo CY, Robins SJ, Sutherland P, Benjamin EJ, Levy D, Fox CS, Am J Cardiol 2008 102 1194 1198 10.1016/j.amjcard.2008.06.039 18940290
8. Serum cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney disease. Muntner P, Mann D, Winston J, Bansilal S, Farkouh ME, Am J Cardiol 2008 102 54 57 10.1016/j.amjcard.2008.02.098 18572035
9. Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Jernberg T, Lindahl B, James S, Larsson A, Hansson LO, Wallentin L, Circulation 2004 110 2342 2348 10.1161/01.CIR.0000145166.44942.E0 15477399 (Pubitemid 39407337)
10. Physical inactivity differentially alters dietary oleate and palmitate trafficking. Bergouignan A, Trudel G, Simon C, Chopard A, Schoeller DA, Momken I, Votruba SB, Desage M, Burdge GC, Gauquelin-Koch G, et al. Diabetes 2009 58 367 376 19017764
11. Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73 m(2) from the cystatin C values in mg/L. Flodin M, Jonsson AS, Hansson LO, Danielsson LA, Larsson A, Scand J Clin Lab Invest 2007 67 560 567 10.1080/00365510601187773 17763193 (Pubitemid 47344352)
12. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, de Jong P, Gansevoort RT, Levey AS, de Jong PE, et al. Kidney Int 2011
13. Cystatin C identifies chronic kidney disease patients at higher risk for complications. Peralta CA, Katz R, Sarnak MJ, Ix J, Fried LF, De Boer I, Palmas W, Siscovick D, Levey AS, Shlipak MG, J Am Soc Nephrol 2011 22 147 155 10.1681/ASN.2010050483 21164029
14. Cystatin C and the risk of death and cardiovascular events among elderly persons. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C, N Engl J Med 2005 352 2049 2060 10.1056/NEJMoa043161 15901858 (Pubitemid 40664306)
15. Update on cystatin C: new insights into the importance of mild kidney dysfunction. Shlipak MG, Praught ML, Sarnak MJ, Curr Opin Nephrol Hypertens 2006 15 270 275 10.1097/01.mnh.0000222694.07336.92 16609294
16. Impact of elevated cystatin C level on cardiovascular disease risk in predominantly high cardiovascular risk populations: a meta-analysis. Lee M, Saver JL, Huang WH, Chow J, Chang KH, Ovbiagele B, Circ Cardiovasc Qual Outcomes 2010 3 675 683 10.1161/CIRCOUTCOMES.110.957696 20923994
17. Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Singh D, Whooley MA, Ix JH, Ali S, Shlipak MG, Nephrol Dial Transplant 2007 22 1087 1092 10.1093/ndt/gfl744 17210589 (Pubitemid 46523422)
18. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Keller CR, Odden MC, Fried LF, Newman AB, Angleman S, Green CA, Cummings SR, Harris TB, Shlipak MG, Kidney Int 2007 71 239 244 10.1038/sj.ki.5002042 17183246 (Pubitemid 46160924)
19. Association between physical activity energy expenditure and inflammatory markers in sedentary overweight and obese women. Lavoie ME, Rabasa-Lhoret R, Doucet E, Mignault D, Messier L, Bastard JP, Faraj M, Int J Obes (Lond) 2010 34 1387 1395 10.1038/ijo.2010.55
20. Cystatin C and cardiovascular risk. Taglieri N, Koenig W, Kaski JC, Clin Chem 2009 55 1932 1943 10.1373/clinchem.2009.128397 19713275
21. Cystatin C and cathepsins in cardiovascular disease. Bengtsson E, Nilsson J, Jovinge S, Front Biosci 2008 13 5780 5786 18508621
22. Calibration of the siemens cystatin C immunoassay has changed over time. Larsson A, Hansson LO, Flodin M, Katz R, Shlipak MG, Clin Chem 2011 57 777 778 10.1373/clinchem.2010.159848 21364028
23. Ammonia functions as a regulatory molecule to mediate adjustments in glomerular filtration rate in response to changes in metabolic rate. Singer MA, Med Hypotheses 2001 57 740 744 10.1054/mehy.2001.1478 11918438 (Pubitemid 34014376)
24. Synovial giant cells in rheumatoid arthritis: expression of cystatin C, but not of cathepsin B. Hansen T, Petrow PK, Gaumann A, Keyszer G, Brauer R, Kriegsmann J, Exp Toxicol Pathol 2000 52 312 316 10.1016/S0940-2993(00)80055-X 10987183 (Pubitemid 30663493)
25. Cystatin C concentration is correlated with disease activity in rheumatoid arthritis patients. Targonska-Stepniak B, Majdan M, Scand J Rheumatol 2011 40 341 346 10.3109/03009742.2011.571219 21619490
26. WISE 2005: chronic bed rest impairs microcirculatory endothelium in women. Demiot C, Dignat-George F, Fortrat JO, Sabatier F, Gharib C, Larina I, Gauquelin-Koch G, Hughson R, Custaud MA, Am J Physiol Heart Circ Physiol 2007 293 3159 3164 10.1152/ajpheart.00591.2007 17766475 (Pubitemid 350106542)
27. Regulation of energy balance during long-term physical inactivity induced by bed rest with and without exercise training. Bergouignan A, Momken I, Schoeller DA, Normand S, Zahariev A, Lescure B, Simon C, Blanc S, J Clin Endocrinol Metab 2010 95 1045 1053 10.1210/jc.2009-1005 20061436
28. Association between physical activity and kidney function: National Health and Nutrition Examination Survey. Hawkins MS, Sevick MA, Richardson CR, Fried LF, Arena VC, Kriska AM, Med Sci Sports Exerc 2011 43 1457 1464 10.1249/MSS.0b013e31820c0130 21200336
29. Effect of body position on renal parenchyma perfusion as measured by nuclear scintigraphy. Schwartz BF, Dykes TE, Rubenstein JN, Stackhouse GB, Stoller ML, Urology 2007 70 227 229 17826475 (Pubitemid 47362241)